IP Library › Granted Patent US 7,294,698
Granted Patent B2
US 7,294,698 · App. 11/591,992 · Granted Nov 13, 2007

Methods and reagents for diagnosis and treatment of diabetes

Assignee: Metabolex, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,294,698
App. No.
11/591,992
Granted
Nov 13, 2007
Kind
B2
Abstract

The invention relates to methods and reagents for diagnosing and treating diabetes.

Claims (1)

1. An isolated polypeptide comprising SEQ ID NO:2.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 7, 2015
From: SILICON VALLEY BANK; OXFORD FINANCE LLC
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 036307/0406 →
SECURITY AGREEMENT Recorded Nov 22, 2013
From: CYMABAY THERAPEUTICS, INC.
To: SILICON VALLEY BANK; OXFORD FINANCE LLC
Reel/Frame 031710/0508 →
CHANGE OF NAME Recorded Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031516/0376 →
Continuity (3)
Division 1030839300 · Dec 2, 2002
Provisional Application 6033663300 · Dec 3, 2001
Related Publication 20070055050A1 · Mar 8, 2007